Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells. (2020)
Attributed to:
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0628-x
PubMed Identifier: 31819183
Publication URI: http://europepmc.org/abstract/MED/31819183
Type: Journal Article/Review
Volume: 122
Parent Publication: British journal of cancer
Issue: 1
ISSN: 0007-0920